667, L.P., Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 177,025 shares at $74.05 ($13.1M) on 2018-11-26, disclosed to the SEC on 2018-11-28.
Open-market sale of $13.1M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.05 | 141 | $10K | 0.1% |
| 2 | $74.05 | 217 | $16K | 0.1% |
| 3 | $74.05 | 126 | $9K | 0.1% |
| 4 | $74.05 | 8,204 | $608K | 4.6% |
| 5 | $74.05 | 10 | $741 | 0.0% |
| 6 | $74.36 | 3,759 |
| $280K |
| 2.1% |
| 7 | $74.36 | 24,487 | $1.8M | 13.9% |
| 8 | $74.36 | 28 | $2K | 0.0% |
| 9 | $74.36 | 376 | $28K | 0.2% |
| 10 | $74.36 | 419 | $31K | 0.2% |
| 11 | $74.36 | 648 | $48K | 0.4% |
| 12 | $73.76 | 43 | $3K | 0.0% |
| 13 | $73.76 | 563 | $42K | 0.3% |
| 14 | $73.76 | 628 | $46K | 0.4% |
| 15 | $73.76 | 970 | $72K | 0.5% |
| 16 | $73.76 | 5,627 | $415K | 3.2% |
| 17 | $73.76 | 36,652 | $2.7M | 20.6% |
| 18 | $74.24 | 1,329 | $99K | 0.8% |
| 19 | $74.24 | 91 | $7K | 0.1% |
| 20 | $74.24 | 2,052 | $152K | 1.2% |
| 21 | $74.24 | 77,558 | $5.8M | 43.9% |
| 22 | $74.24 | 11,907 | $884K | 6.7% |
| 23 | $74.24 | 1,190 | $88K | 0.7% |
| Total | $74.13 avg | 177,025 | $13.1M | 100% |
| Filing → |
| MDGL | BUY | 2023-12-14 | $14.7M | — | Filing → |
| ACAD | BUY | 2023-05-24 | $45.4M | — | Filing → |
| TCRX | BUY | 2022-05-12 | $4.8M | — | Filing → |